Regent Pacific Group Limited (RPG.F)

0.0405 +0.0005 (+1.25%) 收市：08:20AM CEST

Regent Pacific Group Limited

Henley Building
8th Floor 5 Queen's Road
Central
Hong Kong
852 2514 6111
https://www.regentpac.com

版塊: Financial Services
行業: Asset Management
全職員工: 17

高階主管

名稱	頭銜	支付	行使價	出生年份
Mr. Jamie Alexander Gibson	CEO & Executive Director	1.22M	無	1966
Dr. Michael Grant Wyllie BSc, D.Sc., DSc	Co-Founder & Chief Scientific Officer	181.92k	無	1951
Mr. Yui Fui Wong	Chief Financial Officer	無	無	1975
Mr. Paul Eric Jones BA, MBA	Investment Director	無	無	1965
Ms. Mei Yan Lui	Company Secretary	無	無	1975
Prof. John Michael Fitzpatrick FC Urol (SA), FRCS, FRCSGlas, FRCSI, MCh	Chairman of Clinical Scientific Advisory Board	無	無	無

截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 EUR。

描述

Regent Pacific Group Limited, an investment holding company, holds investments in the healthcare and life sciences sectors in Europe and Taiwan. The company operates in two segments, Biopharma and Corporate Investment. It engages in the research, development, manufacture, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of artificial intelligence systems to track the rate of aging at the molecular, cellular, tissue, organ, system, physiological, and psychological levels. The company also invests in listed and unlisted corporate entities. In addition, it provides management services. The company was formerly known as Endurance RP Limited and changed its name to Regent Pacific Group Limited in July 2023. Regent Pacific Group Limited was incorporated in 1991 and is headquartered in Central, Hong Kong.

公司管治

截至 無 止，Regent Pacific Group Limited 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。